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Running title: Perception, reality and actions in obesity. 
 
 
Abstract 
Aims: Despite increased recognition as a chronic disease, obesity remains greatly underdiagnosed and 
undertreated. We aimed to identify international perceptions, attitudes, behaviours and barriers to 
effective obesity care in people with obesity (PwO) and healthcare professionals (HCPs).  
Methods: An online survey was conducted in 11 countries. Participants were adults with obesity and 
HCPs primarily in direct patient care.  
Results: 14,502 PwO and 2,785 HCPs completed the survey. Most PwO (68%) and HCPs (88%) 
agreed that obesity is a disease. However, 81% of PwO assumed complete responsibility for their own 
weight loss and only 44% of HCPs agreed that genetics were a barrier. There was a median of 3 
(mean 6) years between the time when PwO started struggling with excess weight or obesity and 
when they first discussed their weight with an HCP. Many PwO were concerned about the impact of 
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excess weight on health (46%) and were motivated to lose weight (48%). Most PwO (68%) would 
like their HCP to initiate a conversation about weight and only 3% were offended by such a 
conversation. Among HCPs, belief that patients have little interest/motivation for weight management 
may constitute a barrier for weight management conversations. When discussed, HCPs typically 
recommended lifestyle changes; but more referrals and follow-up appointments are required.  
Conclusions: Our international dataset reveals a need to increase understanding of obesity and 
improve education on its physiological basis and clinical management. Realisation that PwO are 
motivated to lose weight offers an opportunity for HCPs to initiate earlier weight management 
conversations.  
Sponsor: Novo Nordisk.  
 
Clinical trial registration number at ClinicalTrials.gov: NCT03584191 
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Introduction 
Obesity is a serious, chronic relapsing disease with high prevalence and a substantial unmet medical 
need.1,2 This complex disease is influenced by multiple factors including genetics, physiological 
factors, psychological issues and environmental variables (physical and social), and affects people of 
all ages and regions.2–4 Obesity is associated with multiple complications and an increased risk of 
disability and mortality.5–7 People living with obesity experience stigma, discrimination and a 
negative impact on both mental and health-related quality of life.4,7,8 
Treatment guidelines for people with obesity (PwO) typically recommend lifestyle interventions with 
addition of pharmacotherapy if response to dietary, physical activity and behavioural changes alone is 
insufficient to reach or maintain the recommended goal of 5–10% body weight loss.9–15 Bariatric 
surgery should be considered for severe cases (body mass index [BMI] ≥40 kg/m2 or ≥35 kg/m2 with 
obesity-related complications), and may be considered for PwO (BMI ≥30 kg/m2) with poorly 
controlled type 2 diabetes.9–15 Despite the availability of these guidelines, in practice PwO experience 
variable care.16–18 The Awareness, Care, and Treatment In Obesity maNagement (ACTION) survey 
study conducted in the US identified low rates of obesity diagnosis and management.19 In another 
survey of 1,506 healthcare professionals (HCPs) in the US, most (84%) demonstrated limited 
knowledge of obesity treatment guidelines.20 An international study of 335 HCPs suggested a 
disconnect between HCPs‟ confidence in their ability to manage patients with excess weight and 
effectiveness in achieving weight loss goals.21 
To improve the quality of, and access to, obesity care globally, a better understanding of the disease 
and the way those with obesity are currently (and should be) managed is required. The objective of 
the ACTION International Observation (ACTION-IO) study was to identify the perceptions, attitudes 
and behaviours of PwO and HCPs and assess the potential barriers to effective obesity care on an 
international scale. Here we report the primary results from ACTION-IO which, to our knowledge, is 
the largest international survey of PwO and HCPs to date. 
 
Methods 
Study design and participants 
ACTION-IO was a cross-sectional, non-interventional, descriptive study that collected data by an 
online survey conducted by a third-party vendor (KJT Group [Honeoye Falls, NY, USA]) utilising 
existing databases/panels in 11 countries across different world regions (Australia, Chile, Italy, Israel, 
Japan, Mexico, Saudi Arabia, South Korea, Spain, UK and UAE) between June 4, 2018 and October 
15, 2018. It was intended to also include Brazil, but it was not possible to obtain local ethics 
committee approval within the required timelines.  
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Eligible PwO were 18 years or older and resident in a participating country, with a current BMI 
(based on self-reported height and weight) of at least 30 kg/m2, or at least 25 kg/m2 in Japan and 
South Korea (as per country-specific definitions of obesity).
22
 PwO were excluded if they declined to 
provide income (with the exception of Mexico as required by the local ethics committee) or 
race/ethnicity (Australia and UAE only), were pregnant, participated in intense fitness or body 
building programmes or had significant, unintentional weight loss in the past 6 months. Eligible HCPs 
were medical practitioners in a participating country, in practice for 2 years or more, with at least 70% 
of time in direct patient care and who had seen 100 or more patients in the past month, at least 10 of 
whom had a BMI of at least 30 kg/m2 (or 25 kg/m2 in Japan and South Korea). HCPs specialising in 
general, plastic or bariatric surgery were excluded.  
All respondents provided electronic informed consent prior to initiation of the screening questions and 
survey. A local ethics committee/independent review board approved the questionnaires in Australia, 
Israel, Mexico, Saudi Arabia, South Korea, Spain, UAE and the UK, where such approval was 
required. For Chile, Italy and Japan, ethical approval was determined to be non-essential for a study of 
this nature based on regulatory standards and precedent. The study complied with all laws and 
regulations regarding management of personal information as required by the participant‟s country of 
residence and the European General Data Protection Regulation. The study was conducted in 
accordance with the Guidelines for Good Pharmacoepidemiology Practices23 and is registered with 
ClinicalTrials.gov, number NCT03584191.  
 
Survey development and pre-testing 
Two questionnaires, one for PwO and one for HCPs (Appendix pp 22–133), were developed by an 
international steering committee of obesity experts (representing primary care, medical specialities 
and psychology) from the participating countries, plus three medical doctors employed by the sponsor 
(Novo Nordisk). The questionnaires were based on those used by the ACTION US19 and ACTION 
Canada studies,24 with minor modification or removal of some original questions to reduce the survey 
length, increase data quality and ensure questions were relevant to the study objectives. KJT Group 
conducted 60-minute web-assisted pretests with four PwO and four HCPs in each country: 
participants took the survey online whilst speaking with a moderator by telephone, or in-person for 
Saudi Arabia, UAE, Japan and South Korea. This was to assess clarity, face validity and relevance of 
the questions. Surveys were designed to facilitate comparisons within and across respondent types. 
 
Procedures 
KJT Group oversaw all aspects of data collection and reporting. Data were collected through an 
online survey programmed by KJT Group using Decipher Survey Software (FocusVision Worldwide 
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Inc., Stamford, CT, USA). To reduce PwO sampling bias and ensure the group was largely 
representative of the general population, the outbound sample was sent according to pre-determined 
demographics targets based on gender, age, income, race/ethnicity (in select countries) and region. 
Targets were established based on data from the 2011 International Standard Classification of 
Education and the US Census Bureau, International Data Base and other public data. Prior to 
participation, respondents were blinded to the specific study goals, being informed that the purpose 
was “to determine treatment experiences of patients with a specific condition”. All individuals could 
access the first part of the survey, and then an initial set of screening questions determined eligibility 
based on the demographic targets; subsequently, only respondents who had obesity (as determined 
from their self-reported height and weight) and who met the other eligibility requirements as detailed 
in the „Study design and participants‟ section proceeded into the full survey. Demographic targets 
were monitored throughout data collection to ensure population representativeness.  
Respondents were compensated for their time and mostly recruited via online panel companies to 
whom they had given permission to be contacted for research purposes (Appendix p 2). Respondents 
were recruited through email where possible, with telephone and in-person recruitment also used for 
PwO in Saudi Arabia and UAE and HCPs in Saudi Arabia, UAE, Japan, South Korea, Israel, Chile 
and Mexico. Respondents completed the survey in the native language of their country. In-person 
administration of the online survey was permitted for PwO in Saudi Arabia and UAE and for HCPs in 
Saudi Arabia, UAE, Japan, South Korea, Israel, Chile and Mexico (Appendix p 2). All respondents 
could suspend taking the survey at any time and for any reason in any part of the survey. Participants 
were only allowed to complete the survey once, as assessed by prior online consent and digital 
fingerprinting (Appendix p 2). To avoid bias, questionnaire items were carefully phrased, presented in 
the same order for each respondent and items in a list were displayed alphabetically, categorically, 
chronologically or randomly as relevant for each response set.   
  
Outcomes 
Outcomes were measured by multiple item selection (weight loss motivators, effective weight loss 
methods, types of weight management goals, most helpful information for patients for weight loss, 
responsibility for improving health of PwO, most helpful support for weight loss and ways 
information is received on weight loss management), numeric response (proportion of PwO who 
made a serious weight loss effort), single item selection (response to weight loss discussions), end-
anchored 5-point Likert agreement scales (attitudes to obesity, attitudes toward prescription weight 
loss medication and surgery, weight loss barriers, obesity and weight management, and the degree to 
which healthcare and society is meeting the needs of PwO), fully anchored 5-point Likert scales 
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(effectiveness of guidelines for treating obesity) and by ranking (top factors for improving weight loss 
outcomes); some of these will be published separately.  
 
Analysis 
The target sample size based on 12 participating countries was 19,700 completed surveys, comprising 
16,500 PwO (750–2,000 per country) and 3,200 HCPs (200–300 per country; 1,600 primary care 
professionals [PCPs] plus 1,600 non-PCP specialties), to balance statistical power, recruitment 
feasibility and cost.  
Analysis of de-identified data was conducted by KJT Group using SPSS (IBM, version 23.0), Stata 
(StataCorp LLC, version IC 14.2) and Excel (Microsoft, version 2016). Data were summarised using 
univariate descriptive statistics (means, medians, frequencies), and tests of differences (chi square, t-
tests) within PwO or HCP respondent types were performed. Statistical significance was set at 
P < 0.05, using 2-tailed tests. Adjustment for multiple testing was not undertaken as this research was 
exploratory and descriptive in nature. Only data from those who completed the survey were included 
in the analyses.  
The final PwO sample, including those failing to qualify for the survey, was weighted to 
representative demographic targets within each country for age, gender, household income, education 
and region (Appendix p 3). HCP data were not weighted.  
 
Results 
A total of 14,502 PwO and 2,785 HCPs completed the survey (Table 1; Supplementary Figure S1) 
as per the target sample size for 11 participating countries. The mean response rate was 20% for PwO 
and 17% for HCPs; the mean eligibility rate was 19% for PwO and 61% for HCPs; the mean 
completion time was 28 minutes for PwO and 35 minutes for HCPs (Appendix p 5).  
Sixty-eight per cent of PwO and 88% of HCPs agreed with the statement that obesity is a chronic 
disease (Supplementary Figure S2A). Most PwO (82%) and HCPs (76%) believed that obesity has a 
large impact on overall health (Supplementary Figure S2B). In comparison, 75–85% of PwO and 
82–93% of HCPs stated that diabetes, stroke, cancer or chronic obstructive pulmonary disease has a 
large impact on overall health. Despite recognising obesity as a disease that impacts overall health, 
most PwO assumed full responsibility for weight loss (81%) and considered lifestyle a key factor in 
their struggle with obesity (63%; Figure 1, items 1–2; see Supplementary Figure S3 for complete 
data). Thirty per cent of HCPs also placed the responsibility for weight loss on PwO, and 79% agreed 
that their patients would need to completely change their lifestyle to lose weight. Only 31% of HCPs 
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thought their patients were motivated to lose weight, whereas 48% of PwO said they were motivated 
to lose weight (Figure 1, item 4) and only 20% of PwO had no plans for weight loss within the next 6 
months (Supplementary Figure S4). Most PwO and HCPs considered unhealthy eating habits (62% 
PwO; 89% HCPs) and lack of exercise (73% PwO; 88% HCPs) as barriers to weight loss, whereas 
fewer than half considered the genetic factors underlying obesity (33% PwO; 44% HCPs) to be a 
barrier (Supplementary Figure S5, items 1, 2 and 15).  
Eighty-one per cent of PwO stated they had made at least one serious weight loss effort in the past 
(Figure 2A). Conversely, on average, HCPs reported that only 35% of their patients with obesity had 
made a serious weight loss effort (Figure 2B). Of patients who had made a serious weight loss 
attempt in the past year, the mean proportion defined by HCPs as responding successfully was 30% 
(Supplementary Figure S6). A substantial proportion of PwO (62%) believed they could lose weight 
if they set their mind to it (Figure 1, item 3). However, many PwO struggled to lose weight and to 
maintain weight loss (Figure 2C,D); only 37% of PwO had a self-reported weight loss of at least 5% 
body mass over the past 3 years, and of those, only 29% were able to maintain the weight loss for at 
least 1 year (11% of PwO total).  
Only about half of all PwO had discussed their weight with an HCP in the past 5 years (Figure 3A). It 
took a median of 3 years and mean of 6 years between the time when PwO said they first started 
struggling with excess weight or obesity and when they first had a weight management conversation 
with an HCP (Figure 3B). Moreover, 46% of PwO who discussed weight with an HCP initiated the 
conversation themselves (Supplementary Figure S7A). In contrast, on average, HCPs reported 
discussing weight with 68% of their patients with obesity with the patient initiating the conversation 
only one third of the time (Supplementary Figure S7B). The main reason HCPs provided for 
initiating a weight management conversation was obesity-related complications (Supplementary 
Figure S8).   
Among PwO who had discussed their weight with an HCP in the past 5 years, 67% had been 
diagnosed with obesity in the past (36% of PwO in total; Figure 3A). On average, HCPs informed 
their patients with obesity that they had a diagnosis of obesity 75% of the time; 6% of HCPs never 
informed their patients of a diagnosis of obesity (Supplementary Figure S9). Only 39% of PwO who 
had discussed their weight with an HCP had a follow-up appointment scheduled (21% of PwO in 
total; Figure 3A); however, 94% of PwO reported attending or planning to attend a follow-up 
appointment if scheduled (Supplementary Figure S10A). On average, HCPs scheduled follow-up 
appointments with 44% of their patients for obesity; 55% of HCPs said patients kept these follow-up 
appointments always or most of the time (Supplementary Figure S10B).  
Among all PwO, 41% would set themselves an ambitious weight loss target of 11–20% 
(Supplementary Figure S11A; overall mean 16%). PwO reported receiving similar recommended 
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targets from HCPs (Supplementary Figure S11B; overall mean 17%). The weight management goals 
most frequently selected by PwO were reducing the risks associated with excess weight/preventing a 
health condition (46%) and to improve appearance (33%; Supplementary Figure S12). 
The most frequent methods for managing weight discussed between PwO and HCPs were general 
improvements in eating habits and general increases in physical activity level, whereas specific diet or 
exercise programmes, tracking, weight loss medications and bariatric surgery were less likely to have 
been discussed (Supplementary Figure S13A). Referrals to specialists were also recommended 
infrequently (Supplementary Figure S13A). General improvements in eating habits and physical 
activity were perceived to be highly effective by most PwO and HCPs; however, more PwO than 
HCPs perceived weight loss medications and bariatric surgery to be effective (Supplementary 
Figure S13B). 
Thirty-five per cent of PwO found conversations with an HCP about weight management very or 
extremely helpful (Supplementary Figure S14), and 68% of PwO liked (or would like) their HCP to 
bring up weight during their appointments (Figure 3C). Conversations with HCPs about weight 
management can be quite motivating and positive for PwO, with 64% reporting positive types of 
feelings after a weight loss conversation (Figure 3D). Negative types of feelings after a weight loss 
conversation were reported by 44% of PwO. However, only 3% of PwO reported feeling offended 
(Figure 3D).  
The top reason PwO provided for not discussing weight management with their HCP was a belief that 
it was their own responsibility to manage their weight (selected by 44% of PwO vs 9% of HCPs), 
whereas the top reason HCPs provided for not discussing obesity with a patient was if they perceived 
the patient to be not interested in losing weight (selected by 71% of HCPs vs 7% of PwO; Figure 4; 
see Supplementary Figure S15 for complete data). More than half of HCPs indicated that the limited 
appointment time would also be a factor in not having a weight loss conversation (Figure 4). Data for 
other outcomes are presented in Supplementary Figures S16–S19. 
 
Discussion 
The ACTION-IO study identified several key gaps in obesity care and misalignment between the 
perceptions and attitudes of PwO and HCPs. PwO and HCPs stated they recognised obesity as a 
chronic disease; however, most PwO assumed complete responsibility for weight loss. Furthermore, 
both PwO and HCPs put emphasis on lifestyle-related factors rather than biological factors, including 
genetic predisposition, as significant barriers to weight loss. The results suggest many PwO are 
concerned about the impact of their excess weight on health and are making serious efforts to lose 
weight, but have a limited response on their own. In contrast, HCPs‟ belief that PwO are not 
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interested or motivated to lose weight may be preventing weight loss conversations. This might reflect 
the actual experience of the HCPs or represent an unconscious negative bias.  
Obesity is recognised as a chronic disease by several national and international organisations, 
including the World Obesity Federation,1 European Association for the Study of Obesity,11 The 
Obesity Society25 the American Medical Association26 and the UK Royal College of Physicians.27 
Obesity has a genetic predisposition and specific pathophysiological alterations, and is not just due to 
lifestyle.3,4 However, only 26% of PwO in this study agreed that their HCP has a responsibility to 
actively contribute to their weight loss efforts. Other studies have previously highlighted 
disconnection between perceptions and actions. In a study in Australia, 78% of PwO agreed that their 
HCP had a role in their weight management, but only 58% would ask their HCP for weight loss 
advice.28  
Compared with the US ACTION study, a smaller proportion of PwO in this international study had 
discussed their weight with an HCP in the past 5 years (US ACTION 71%, ACTION-IO 54%); but of 
those, a greater proportion had received a diagnosis of obesity (US ACTION 55%, ACTION-IO 
67%).19 A similar proportion of PwO in the US and internationally thought their weight loss was 
completely their responsibility (US ACTION 82%, ACTION-IO 81%), and this was the top reason for 
PwO not initiating a weight management conversation with an HCP in both studies.19 In the US, 
HCPs cited lack of time as a top reason for not initiating weight loss conversations,19 whereas 
internationally, HCPs selected limited patient motivation or patient disinterest in losing weight as top 
reasons, in stark contrast to PwO responses and reflecting an educational need.  
A potential barrier to effective obesity care identified here was the length of time (years) between 
when PwO started struggling with their weight and when they first had a weight management 
conversation with an HCP. Decreasing this time gap could reduce the complications of obesity 
experienced by PwO and ultimately lessen the economic cost of the disease.6,7 Appropriate and 
supportive weight management conversations should be initiated earlier as a preventive approach, 
before complications occur. Jointly agreeing a patient has overweight or obesity with a BMI 
calculation in the context of their personal health profile may be an effective way to initiate such a 
conversation.29 Discussing the genetic component and biological contributors to obesity4,30 with the 
patient, using explanatory illustrations that are tailored to the patient‟s knowledge base, where 
relevant, could help diminish self-blame and encourage continued dialogue and receptivity of support 
from the HCP. Recognising positive patient responses to conversational cues may allow for the 
provision of therapeutic intervention (or development of a management plan).9,15,31  
Our data suggest that PwO are motivated for weight loss efforts and would like for their HCP to 
initiate a conversation about weight. This is consistent with a UK study showing that most patients 
found discussing their weight with an HCP appropriate and helpful.32 As a chronic disease, there is 
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also a need to improve referrals and follow-up appointments for management of obesity. Part of this 
effort will mean eradicating the prevalent stigmatising attitudes highlighted in prior studies33 and 
HCPs‟ misperception that PwO are not motivated, shown here. The weight loss targets reported in this 
study were higher than achievable for most PwO with existing non-surgical interventions, as 
demonstrated by the low proportion of PwO who had achieved and maintained a weight loss of at 
least 10%. Setting realistic and achievable weight loss goals could help manage expectations, with 
collaborative communication and more manageable targets potentially providing encouragement for 
continued patient engagement. Guidelines suggest a weight loss goal of 5–10%, depending on the 
severity of obesity, over a period of 6 months.10 However, even a 3% to 5% reduction in weight can 
provide clinically meaningful health benefits.34 Opportunities for improving obesity management 
include: improving education of PwO, HCPs, HCP students, governments and the public on the 
biological basis of obesity and challenging the misperception that obesity is under a person‟s 
control;33 obtaining unanimous recognition of obesity as a chronic progressive disease; addressing 
HCPs‟ attitudes towards PwO; promoting initiation of helpful weight loss conversations earlier; 
improving education of HCPs and HCP students on the clinical management of obesity (effective 
advice on diet, physical activity, medical and surgical therapy) and the value of a multidisciplinary 
approach;9–15 and increasing the frequency of diagnosis, follow-up appointments and referrals for 
effective evidence-based treatment. Obesity is an adiposity-based chronic disease, the whole 
complexity of which cannot be reflected by BMI alone,35 and this may contribute to the reluctance of 
HCPs to provide a diagnosis of obesity. However, as recommended by the current clinical practice 
guidelines, BMI is used for the initial assessment and diagnosis of obesity, taking into account factors 
such as age, ethnicity and muscularity.9–15 
Limitations of this study include the cross-sectional and descriptive nature, and reliance on self-
reported height and weight (which could underestimate BMI) and accurate respondent recall. The 
fairly low response rates were typical for survey-based research (Appendix p 5). Low response rates 
can affect sample representativeness and are a known limitation for this type of study. Internet access 
could also have restricted participation in some countries. Strengths include the large number of 
respondents, international nature of the study and scientific rigor in the survey design and 
implementation, including the stratified sampling to provide a representative general population 
group. 
Overall, our data suggest that PwO are motivated to lose weight and there is an opportunity for HCPs 
to initiate earlier, effective weight loss conversations with minimal fear of offence. PwO may not 
recognise the need to reduce excess weight until it has an impact on their health, further supporting 
the requirement for HCPs to raise the topic of weight before such obesity-related complications occur. 
Our study also reveals a global need for greater education for both PwO and HCPs on the biological 
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basis and clinical management of obesity, and for a more positive HCP attitude towards initiating 
weight discussions and management.  
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Figure legends 
 
FIGURE 1 PwO and HCP agreement with statements regarding attitudes towards obesity. Rated on a 
scale 1–5. Abbreviations: HCP, healthcare professional; PwO, people with obesity  
 
FIGURE 2 Weight loss efforts and response to intervention. (A) Number of past serious weight loss 
attempts (PwO). (B) Proportion of patients considered to have made a serious weight loss effort 
reported by HCPs. (C, D) PwO extent and maintenance of weight loss in last 3 years at threshold of 
(C) 5% or (D) 10% of total body weight. HCPs = green; PwO = orange. Abbreviations: HCP, 
healthcare professional; PwO, people with obesity 
 
FIGURE 3 Weight management conversations and outcomes. (A) Proportion of PwO having weight 
management discussions with an HCP, obesity diagnoses and follow-up appointments/calls. (B) Of 
PwO who had discussed their weight with a HCP in the past 5 years, proportion who had the 
discussion less than 2 years, 3–5 years, 6–10 years or more than 10 years after they first started 
struggling with their weight. (C) Proportion of PwO who like or would like their HCP to bring up 
weight during appointments. (D) PwO feelings after discussing their weight with an HCP. HCPs = 
green; PwO = orange. Abbreviations: HCP, healthcare professional; PwO, people with obesity 
 
FIGURE 4 Reasons for not discussing weight with an HCP (PwO, orange) or patient (HCPs, green), 
with at least 10% difference between PwO and HCPs. See Supplementary Figure S15 for all reasons. 
HCPs = green; PwO = orange. Abbreviations: HCP, healthcare professional; PwO, people with 
obesity 
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TABLE 1 Sample demographics and characteristics  
 
PwO 
(n = 14,502) 
HCPs  
(n = 2,785) 
Age, years  43 (18–88) 48 (26–74)  
Gender   
Male 7,438 (51%) 1,958 (70%) 
Female 7,050 (49%) 827 (30%) 
Other 14 (<1%) 0 
Country  
Australia 1,000 (7%) 200 (7%) 
Chile 1,000 (7%) 200 (7%) 
Italy 1,501 (10%) 302 (11%) 
Israel 750 (5%) 169 (6%) 
Japan 2,001 (14%) 302 (11%) 
Mexico 2,000 (14%) 400 (14%) 
Saudi Arabia 1,000 (7%) 200 (7%) 
South Korea 1,500 (10%) 200 (7%) 
Spain 1,500 (10%) 306 (11%) 
UK 1,500 (10%) 306 (11%) 
UAE  750 (5%) 200 (7%) 
BMI classification for Australia, Chile, Italy, Israel, Mexico, Saudi Arabia, Spain, UK and 
UAE†  
Respondents 11,001 (100%) 1,778 (78%) 
Underweight or healthy range (<25 kg/m
2
) – 971 (55%) 
Overweight (25–29.9 kg/m2) – 668 (38%) 
Obesity Class I (30–34.9 kg/m2) 6,930 (63%) 103 (6%) 
Obesity Class II (35–39.9 kg/m2) 2,416 (22%) 12 (1%) 
Obesity Class III (≥40 kg/m2)  1,655 (15%) 24 (1%) 
BMI classification for Japan and South Korea‡  
Respondents 3,501 (100%) 418 (83%) 
BMI <25 kg/m2 – 325 (78%) 
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Abbreviations: BMI, body mass index; HCP, healthcare professional; PCP, primary care physician.  
Data are median (range) or number (%) and are reported for the final unweighted sample.  
†Classes I (BMI 30–34.9 kg/m2), II (BMI 35–39.9 kg/m2) and III (BMI ≥40 kg/m2) apply to Australia, 
Chile, Italy, Israel, Mexico, Saudi Arabia, Spain, UK and UAE. 
‡Classes 1 (BMI 25–29.9 kg/m2), 2 (BMI 30–34.9 kg/m2), 3 (BMI 35–39.9 kg/m2) and 4 (BMI ≥40 
kg/m2) apply to Japan and South Korea. 
§Bariatric surgeons were ineligible per protocol pre-specified criteria. 
Obesity Class 1 (25–29.9 kg/m2) 2,696 (77%) 83 (20%) 
Obesity Class 2 (30–34.9 kg/m2) 530 (15%) 9 (2%) 
Obesity Class 3 (35–39.9 kg/m2) 134 (4%) 0 
Obesity Class 4 (≥40 kg/m2)  141 (4%) 1 (<1%) 
Number of comorbidities 
0 3,829 (26%)  
1 3,610 (25%)  
2 2,868 (20%)  
3 2,060 (14%)  
≥4 2,136 (15%)  
HCP category 
PCP  1,415 (51%) 
Specialist  1,370 (49%) 
Diabetologist/endocrinologist  488 (18%) 
Cardiologist  301 (11%) 
Internal medicine (non-PCP)  272 (10%) 
Gastroenterologist  160 (6%) 
Obstetrician/gynaecologist  133 (5%) 
Nutritionist (Italy only)  9 (<1%) 
Bariatrics/obesity medicine§  5 (<1%) 
Hepatologist (Australia only)  2 (<1%) 
Obesity specialist¶ 
Yes  1,868 (67%) 
No  917 (33%) 
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¶A physician who meets at least one of the following criteria: at least 50% of their patients are seen for 
obesity/weight management, or has advanced/formal training in treatment of obesity/weight 
management beyond medical school, or considers themself to be an expert in obesity/weight loss 
management, or works in an obesity service clinic. 
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1a. My weight loss is completely my responsibility
1b. My patients' weight loss is completely their responsibility
2a. For me to lose weight, I would need to completely change my lifestyle
2b. For my patients to lose weight, they would need to completely change their lifestyles
3a. I could lose weight if I really set my mind to it
3b. My patients could lose weight if they really set their mind to it
4a. I am motivated to lose weight
4b. My patients are motivated to lose weight
5a. I know how to lose weight
5b. My patients know what they need to do to lose weight
6a. I know how to keep the weight off
6b. My patients know how to keep the weight off
7a. I do not feel comfortable bringing up my weight unless my HCP mentions it first
7b. I do not feel comfortable bringing up my patients' weight unless they mention it first
8a. I am past the point where I can lose weight on my own
8b. My patients are past the point where they can lose weight on their own
9a. My HCP has a responsibility to actively contribute to a successful weight loss effort
9b. I have a responsibility to actively contribute to my patients' weight loss effort
10a. If I lost weight, it would be easy for me to keep the weight off
10b. If my patients lost weight, it would be easy for them to keep the weight off
11a. Obesity is less important to me than other diseases
11b. Obesity is less important to me than many of the other diseases I treat
12a. There is nothing my doctor can do to help me manage my weight
12b. There is nothing I can do to help patients manage their weight
13a. It is easy for me to lose weight
13b. It is easy for my patients to lose weight
14a. I am happy with my current weight
14b. My patients are happy with their current weight
PwO, n = 14,502
HCPs, n = 2,785
Q500/503
Attitudes towards obesity
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